Azora Therapeutics, Inc. AZR
3.87 USD +0.07 (+1.84%)
Regular-session close
3.96 +0.09 +2.33%
After hours · Nov 19, 6:13 PM ET
3.60 Day range 4.10
1.31 52-week range 8.25
- YTD
- -29.64%
- 1 year
- -51.63%
No chart data for this range yet.
- Market cap
- 55.29M
- EPS (ttm)
- -18.09
- YTD return
- -29.64%
- 1-year return
- -51.63%
- Volume
- 85.99K
- Avg volume
- 50.06K
- Open
- 4.10
- Previous close
- 3.80
- Day's range
- 3.60 – 4.10
- 52-week range
- 1.31 – 8.25
Fundamental scorecard
6 of 25 checks passed on AZR’s reported financials
6of 25 checks passed
- Value 0 of 5
- Growth 1 of 5
- Profitability 0 of 5
- Financial health 5 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
AZR Revenue — quarterly 0
AZR Net income — quarterly -64.56M
AZR EPS — quarterly -4.52
News
Azora Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) Azora Therapeutics Files Prospectus For $250M Mixed Securities Shelf; May Sell Up To $20M Of Stock Under Sales Agreement With Jefferies
Azora Therapeutics Reports 2026 Third Quarter Financial Results and Provides Business Update
Azora Therapeutics Appoints Board of Directors with Extensive Drug Development and Inflammatory Bowel Disease Expertise Jones Trading Initiates Coverage On Azora Therapeutics with Buy Rating, Announces Price Target of $14
12 Health Care Stocks Moving In Friday's Intraday Session
Azarga Metals 2026 Marg Project Drill Program; Keno Hill District, Yukon
Azarga Metals Security Awards
Azarga Metals NI 43-101 Technical Report Filed for the Marg Project, Central Yukon
Azarga Metals Exercised Option to Purchase a 100% Interest in the Marg Project, Central Yukon
Your note
Sign in to keep a note on AZR — it syncs with the Stock Master app.
